Our goal is to provide upgrades for the immune system to counteract age-related tissue decline.
CEO
Bioinformatician with a first-principles track record across human genetics at Trinity College Dublin, plant genetics during his PhD at Warwick, and neurodegenerative-ageing diagnostics in Paris, where he developed aptamer-based plasma biomarkers for brain amyloid. Author of 8 publications and inventor on 2 patents.
CSO
Immunotherapy specialist trained at the University of Crete and Institut Curie. Spent four years at Curie scaling immuno-oncology partnerships, then advanced three programs to late preclinical as Director of Immunotherapy at Mnemo Therapeutics. Inventor on 10 patent families and an author on landmark papers in Cancer Discovery and Nature Biomedical Engineering.
Immunology
Former CSO of Mnemo Therapeutics, Director of Immunotherapy Center, Institut Curie
Clinical Pulmonology
Professor of Pulmonology Univ Versailles SQ, Director of Institut du Thorax
Senescence and Ageing
Co-founder of Stimunity, Group leader in Institut Curie
Antibody Development
Former Director at Boehringer Ingelheim, Former VP at Merus, CSO of Biomunex Therapeutics
Operations & Finance
Former CEO/CFO of Nuclera, Industry Fellow Univ Cambridge, Co-founder of New Co
Software & Open Science
PhD Cambridge, Founder Swan & Metro, Maintainer Open Science Archive
